Sino-Life Group (Sino-Life) reported unaudited interim results for the six months ended 30 June 2026 showing a sharp contraction in revenue and a wider net loss amid softer funeral-service demand in Mainland China.

Revenue and Profitability • Consolidated revenue fell 26.50 % year on year to RMB 26.47 million, driven by a 25.60 % drop in Mainland China funeral, cremation and cemetery income to RMB 25.52 million. • Gross profit declined 23.34 % to RMB 10.13 million, but gross margin edged up to 38.3 % (1H 2025: 36.7 %) on tighter cost control. • Loss attributable to owners widened to RMB 11.08 million from RMB 4.80 million a year earlier; basic and diluted loss per share both increased to RMB 11.72 cents. • Finance costs fell to RMB 0.51 million (-31.79 %), reflecting lower interest on bank and lease liabilities.

Segment Performance • Funeral services remained the core business, contributing 99.9 % of group revenue. • Biotechnical and other businesses generated RMB 29 thousand following a soft launch of new-energy unmanned ground-effect vehicles and related products. • Taiwan revenue rose 10.40 % to RMB 0.69 million; Hong Kong revenue slid to RMB 0.27 million.

Balance Sheet and Liquidity • Cash and bank balances stood at RMB 90.52 million (31 Dec 2025: RMB 98.43 million); net cash used in operating activities amounted to RMB 2.91 million. • Net current assets totalled RMB 47.57 million, down from RMB 54.54 million at year-end. • Total assets were RMB 207.63 million against total liabilities of RMB 121.87 million, producing a gearing ratio of 58.7 % (31 Dec 2025: 57.2 %). • Convertible bonds (issued August 2023) carried a fair-value liability of RMB 11.89 million; no conversion occurred during the period. • Investment properties of RMB 18.63 million were pledged as security for NTD-denominated bank borrowings of RMB 0.53 million.

Capital Management • No interim dividend was proposed. • The company held 1.85 million outstanding share options (exercise price: HK $1.37) and 4.83 million options remained available for future grant. • Capital commitments were unchanged at RMB 2.69 million, mainly for an associate investment and an FVTOCI financial asset.

Outlook Management plans to sustain an “asset-light” strategy in Taiwan’s stable funeral market while accelerating commercial deployment of biotechnology assets in Mainland China’s fast-growing low-altitude economy, supported by continued cost discipline and liquidity preservation.